182 related articles for article (PubMed ID: 19668929)
1. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
[No Abstract] [Full Text] [Related]
2. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
4. Vaccination: A durable design.
Sanderson K
Nature; 2012 Aug; 488(7413):S7. PubMed ID: 22932439
[No Abstract] [Full Text] [Related]
5. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
Vetter KM; Geller SE
J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
[TBL] [Abstract][Full Text] [Related]
6. One in four California adolescent girls have had human papillomavirus vaccination.
Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J
Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623
[No Abstract] [Full Text] [Related]
7. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N; Manalastas R; Pitisuttithum P; Tresukosol D; Monsonego J; Ault K; Clavel C; Luna J; Myers E; Hood S; Bautista O; Bryan J; Taddeo FJ; Esser MT; Vuocolo S; Haupt RM; Barr E; Saah A
Lancet; 2009 Jun; 373(9679):1949-57. PubMed ID: 19493565
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against human papillomavirus.
Mello CF
Einstein (Sao Paulo); 2013 Dec; 11(4):547-9. PubMed ID: 24488402
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and prevention of Human Papillomavirus.
Manini I; Montomoli E
Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
[TBL] [Abstract][Full Text] [Related]
10. Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine.
Zhang Z; Zhang J; Xia N; Zhao Q
Hum Vaccin Immunother; 2017 Oct; 13(10):2280-2291. PubMed ID: 28699820
[TBL] [Abstract][Full Text] [Related]
11. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe.
Soldan K; Dillner J
Euro Surveill; 2006 Nov; 11(11):E061123.3. PubMed ID: 17213557
[No Abstract] [Full Text] [Related]
12. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
[TBL] [Abstract][Full Text] [Related]
13. Clinical approval: Trials of an anticancer jab.
Clayton J
Nature; 2012 Aug; 488(7413):S4-6. PubMed ID: 22932438
[No Abstract] [Full Text] [Related]
14. Mandating HPV vaccination: what are the arguments?
Smith CM
J Christ Nurs; 2008; 25(2):74-80; quiz 81-2. PubMed ID: 18401926
[No Abstract] [Full Text] [Related]
15. Beyond resumption of the Japanese Government's recommendation of the HPV vaccine.
Ueda Y; Yagi A; Ikeda S; Enomoto T; Kimura T
Lancet Oncol; 2018 Dec; 19(12):1563-1564. PubMed ID: 30507414
[No Abstract] [Full Text] [Related]
16. The new HPV vaccination.
Bedford H
Community Pract; 2008 Aug; 81(8):36-7. PubMed ID: 18834017
[No Abstract] [Full Text] [Related]
17. Realities of alternative HPV vaccination schedules.
Stanley M
Salud Publica Mex; 2018; 60(6):617-620. PubMed ID: 30699265
[No Abstract] [Full Text] [Related]
18. Public health: Prevention comes of age.
Eisenstein M
Nature; 2012 Aug; 488(7413):S11-3. PubMed ID: 22932434
[No Abstract] [Full Text] [Related]
19. Elimination of cervical cancer depends on HPV vaccination and primary HPV screening.
Harper DM; Jimbo M
Lancet Infect Dis; 2021 Oct; 21(10):1342-1344. PubMed ID: 34081924
[No Abstract] [Full Text] [Related]
20. HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
Stanley M; Dull P
Vaccine; 2018 Aug; 36(32 Pt A):4759-4760. PubMed ID: 29754700
[No Abstract] [Full Text] [Related]
[Next] [New Search]
